Our goal is to be the leader in developing and selling advanced seedlings by revolutionizing the productivity of the global commercial forestry industry. ArborGen is the largest provider of tree seedling products with more than 5,000 customers, operating in some of the largest planted forest markets in the world: the United States, New Zealand, Australia and Brazil.
ArborGen's leadership position results from having:
a well established commercial business with approximately 250 million seedlings sold per year;
key germplasm for all primary markets, which includes the Southeastern United States, New Zealand, Australia and Brazil;
an industry-leading research and discovery program;
a robust pipeline of 15 biotechnology and six advanced seedling products, including Pine, Populus and Eucalyptus species, that are designed to significantly raise the value of our customers' land;
the largest number of field trials in the United States and Brazil with over 150 active field trials;
a strong intellectual property position, including through patent protection and license agreements;
the first and only petition for deregulation of a biotechnology forestry product under review by the United States Department of Agriculture;
a proven, scalable and integrated business model; and
a world class management team with considerable expertise in forestry and biotechnology and a track record of successfully navigating biotechnology products through the USDA regulatory process.